StemMedical A/S: Financial statements 2014
CVR: 35852808
Source: annual report 2014, Danish Business Authority
01/01/2014 – 31/12/2014
StemMedical A/S (CVR 35852808) has filed annual accounts for 2014. In 2014, the company reported a gross profit of DKK -79,971 and a net result of DKK -197,505. Equity in the 2014 report amounted to DKK -103,755.
- Gross Profit
- DKK -79,971
- Profit/Loss
- DKK -197,505
- Equity
- DKK -103,755
- Total Assets
- DKK 2,199,183
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2014
As of May 2, 2014, LUNI REVISIONS ANPARTSSELSKAB has been appointed auditor of StemMedical A/S.
As of May 2, 2014, Peter Bo Selvig has joined the board of directors of StemMedical A/S.
As of May 2, 2014, Frederik Kølle is registered as chairman of StemMedical A/S.
As of May 2, 2014, Peter Bo Selvig is registered as director of StemMedical A/S.
StemMedical A/S was founded on May 2, 2014.
About StemMedical A/S
StemMedical A/S was a Danish company of the type Aktieselskab based in Søborg, founded in 2014. The company has been dissolved on 25 September 2025. The company was registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named STEMFORM A/S and STEMFORM ApS. The company has 18 employees (2024). In 2022, the company reported a gross profit of DKK -7,902,529 and a net result of DKK -18,876,055 compared with DKK -13,221,367 the year before. Equity in the 2022 report amounted to DKK 12,392,865.